# Convalescent Plasma for COVID-19

> **NCT04365439** · NA · UNKNOWN · sponsor: **Enos Bernasconi** · enrollment: 11 (actual)

## Conditions studied

- Blood Plasma Therapy
- COVID

## Interventions

- **BIOLOGICAL:** Blood plasma

## Key facts

- **NCT ID:** NCT04365439
- **Lead sponsor:** Enos Bernasconi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-20
- **Primary completion:** 2020-12-20
- **Final completion:** 2021-06-30
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04365439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04365439, "Convalescent Plasma for COVID-19". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT04365439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*